Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

274 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chemoprevention of colorectal cancer.
Clapper ML, Chang WC, Meropol NJ. Clapper ML, et al. Among authors: meropol nj. Curr Opin Oncol. 2001 Jul;13(4):307-13. doi: 10.1097/00001622-200107000-00015. Curr Opin Oncol. 2001. PMID: 11429490 Review.
The current status of toxicity protectants in cancer therapy.
Schuchter LM, Luginbuhl WE, Meropol NJ. Schuchter LM, et al. Among authors: meropol nj. Semin Oncol. 1992 Dec;19(6):742-51. Semin Oncol. 1992. PMID: 1334280 Review.
High-dose chemotherapy with autologous stem cell support for breast cancer.
Meropol NJ, Overmoyer BA, Stadtmauer EA. Meropol NJ, et al. Oncology (Williston Park). 1992 Dec;6(12):53-60, 63; discussion 63-4, 69. Oncology (Williston Park). 1992. PMID: 1467164 Review.
Metastatic colorectal cancer: advances in biochemical modulation and new drug development.
Meropol NJ, Creaven PJ, Petrelli NJ. Meropol NJ, et al. Semin Oncol. 1995 Oct;22(5):509-24. Semin Oncol. 1995. PMID: 7570061 Review. No abstract available.
A pilot trial of 5-FU, leucovorin, and cisplatin with or without adriamycin in advanced cancer.
Vaughn DJ, Meropol NJ, Armstead B, Haller DG. Vaughn DJ, et al. Among authors: meropol nj. Am J Clin Oncol. 1996 Jun;19(3):241-4. doi: 10.1097/00000421-199606000-00006. Am J Clin Oncol. 1996. PMID: 8638533 Clinical Trial.
A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer.
Rodríguez-Bigas MA, Klippenstein D, Meropol NJ, Weber TK, Petrelli NJ. Rodríguez-Bigas MA, et al. Among authors: meropol nj. Cryobiology. 1996 Dec;33(6):600-6. doi: 10.1006/cryo.1996.0063. Cryobiology. 1996. PMID: 8975687
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program Trial.
Vaughn DJ, Meropol NJ, Holroyde C, Mintzer D, Nuamah I, Armstead B, Douglass HO Jr, Haller DG. Vaughn DJ, et al. Among authors: meropol nj. Am J Clin Oncol. 1997 Jun;20(3):242-6. doi: 10.1097/00000421-199706000-00006. Am J Clin Oncol. 1997. PMID: 9167745 Clinical Trial.
Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ, Noel D, Sonnichsen DS, Birkhofer MJ. Meropol NJ, et al. Oncology (Williston Park). 1997 Sep;11(9 Suppl 10):22-5. Oncology (Williston Park). 1997. PMID: 9348562 Clinical Trial.
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin.
Meropol NJ, Blumenson LE, Creaven PJ. Meropol NJ, et al. Am J Clin Oncol. 1998 Apr;21(2):135-8. doi: 10.1097/00000421-199804000-00007. Am J Clin Oncol. 1998. PMID: 9537197 Clinical Trial.
Oral fluoropyrimidines in the treatment of colorectal cancer.
Meropol NJ. Meropol NJ. Eur J Cancer. 1998 Sep;34(10):1509-13. doi: 10.1016/s0959-8049(98)00226-3. Eur J Cancer. 1998. PMID: 9893621 Review.
274 results
Jump to page
Feedback